Respiratory Intensive Care Unit management and efficacy during the COVID-19 outbreak in Naples, Italy

Giorgio E Polistina1, Camilla Di Somma2, Martina Flora3

  • 1Sub-Intensive Care Unit and Respiratory Physiopathology Department, Cotugno-Monaldi Hospital, AORN Ospedali dei Colli, Naples. giorgiopolistina@gmail.com.

Insights

The COVID-19 pandemic overwhelmed Intensive Care Units (ICUs). Respiratory Intensive Care Units (RICUs) provided crucial non-invasive support for patients with moderate to severe respiratory failure, optimizing care during the crisis.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The COVID-19 pandemic caused a global health crisis, leading to severe respiratory illness in a significant percentage of patients.
  • Intensive Care Unit (ICU) capacity, including beds and mechanical ventilators, was rapidly saturated worldwide due to the surge in severe COVID-19 pneumonia cases.
  • Non-invasive respiratory support emerged as a critical strategy for managing respiratory conditions and optimizing healthcare resource allocation.

Purpose of the Study:

  • To describe the clinical outcomes and baseline characteristics of patients admitted to a Respiratory Intensive Care Unit (RICU).
  • To evaluate the role of RICUs in managing patients with moderate to severe respiratory failure during the COVID-19 pandemic.
  • To highlight the importance of RICUs as a valuable resource when ICU capacity is limited.

Main Methods:

  • Retrospective analysis of patients admitted to the RICU at Cotugno Hospital, Naples, Italy.
  • Data collection from January 2021 to October 2021.
  • Focus on clinical outcomes and baseline characteristics of patients receiving non-invasive respiratory support.

Main Results:

  • Patients with moderate to severe respiratory failure were successfully managed in the RICU.
  • RICU admission provided an alternative to ICU for patients requiring non-invasive respiratory support.
  • This approach helped alleviate pressure on ICU resources.

Conclusions:

  • Respiratory Intensive Care Units (RICUs) are essential for managing respiratory failure during pandemics.
  • RICUs facilitate effective patient care by utilizing non-invasive respiratory support, thereby optimizing ICU resource utilization.
  • The study underscores the strategic importance of RICUs in healthcare systems facing capacity challenges.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
188
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
324
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
289
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
430
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
282
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
201